Ban, TA; Fujimori, M; Petrie, WM; Ragheb, M; Wilson, WH (1982). ”Systematic studies with amoxapine, a new antidepressant”. International Pharmacopsychiatry 17 (1): sid. 18–27. doi:10.1159/000468553. PMID 7045016.
Kapur, S; Cho, R; Jones, C; McKay, G; Zipursky, RB (May 1999). ”Is amoxapine an atypical antipsychotic? positron-emission tomography investigation of its dopamine2 and serotonin2 occupancy”. Biological Psychiatry 45 (9): sid. 1217–1220. doi:10.1016/S0006-3223(98)00204-2. PMID 10331115.
Wadenberg, M-LG; Sills, TL; Fletcher, PJ; Kapur, S (April 2000). ”Antipsychoticlike effects of amoxapine, without catalepsy, using the prepulse inhibition of the acoustic startle reflex test in rats”. Biological Psychiatry 47 (7): sid. 670–676. doi:10.1016/S0006-3223(99)00267-X. PMID 10745061.
Apiquian, R; Fresan, A; Ulloa, RE; de la Fuente-Sandoval, C; Herrera-Estrella, M; Vazquez, A; Nicolini, H; Kapur, S (December 2005). ”Amoxapine as an atypical antipsychotic: a comparative study vs risperidone”. Neuropsychopharmacology 30 (12): sid. 2236–2244. doi:10.1038/sj.npp.1300796. PMID 15956984.
Chaudhry, IB; Husain, N; Khan, S; Badshah, S; Deakin, B; Kapur, S (December 2007). ”Amoxapine as an Antipsychotic: Comparative Study Versus Haloperidol”. Journal of Clinical Psychopharmacology 27 (6): sid. 575–581. doi:10.1097/jcp.0b013e31815a4424. PMID 18004123.
Sa, DS; Kapur, S; Lang, AE (July–August 2001). ”Amoxapine Shows an Antipsychotic Effect but Worsens Motor Function in Patients with Parkinson's Disease and Psychosis”. Clinical Neuropharmacology 24 (4): sid. 242–244. doi:10.1097/00002826-200107000-00010. PMID 11479398.
Gelenberg, AJ; Cooper, DS; Doller, JC; Maloof, F (October 1979). ”Galactorrhea and Hyperprolactinemia Associated With Amoxapine Therapy”. JAMA 242 (17): sid. 1900–1901. doi:10.1001/jama.1979.03300170046029. PMID 573343.
Ban, TA; Fujimori, M; Petrie, WM; Ragheb, M; Wilson, WH (1982). ”Systematic studies with amoxapine, a new antidepressant”. International Pharmacopsychiatry 17 (1): sid. 18–27. doi:10.1159/000468553. PMID 7045016.
Kapur, S; Cho, R; Jones, C; McKay, G; Zipursky, RB (May 1999). ”Is amoxapine an atypical antipsychotic? positron-emission tomography investigation of its dopamine2 and serotonin2 occupancy”. Biological Psychiatry 45 (9): sid. 1217–1220. doi:10.1016/S0006-3223(98)00204-2. PMID 10331115.
Wadenberg, M-LG; Sills, TL; Fletcher, PJ; Kapur, S (April 2000). ”Antipsychoticlike effects of amoxapine, without catalepsy, using the prepulse inhibition of the acoustic startle reflex test in rats”. Biological Psychiatry 47 (7): sid. 670–676. doi:10.1016/S0006-3223(99)00267-X. PMID 10745061.
Apiquian, R; Fresan, A; Ulloa, RE; de la Fuente-Sandoval, C; Herrera-Estrella, M; Vazquez, A; Nicolini, H; Kapur, S (December 2005). ”Amoxapine as an atypical antipsychotic: a comparative study vs risperidone”. Neuropsychopharmacology 30 (12): sid. 2236–2244. doi:10.1038/sj.npp.1300796. PMID 15956984.
Chaudhry, IB; Husain, N; Khan, S; Badshah, S; Deakin, B; Kapur, S (December 2007). ”Amoxapine as an Antipsychotic: Comparative Study Versus Haloperidol”. Journal of Clinical Psychopharmacology 27 (6): sid. 575–581. doi:10.1097/jcp.0b013e31815a4424. PMID 18004123.
Sa, DS; Kapur, S; Lang, AE (July–August 2001). ”Amoxapine Shows an Antipsychotic Effect but Worsens Motor Function in Patients with Parkinson's Disease and Psychosis”. Clinical Neuropharmacology 24 (4): sid. 242–244. doi:10.1097/00002826-200107000-00010. PMID 11479398.
Gelenberg, AJ; Cooper, DS; Doller, JC; Maloof, F (October 1979). ”Galactorrhea and Hyperprolactinemia Associated With Amoxapine Therapy”. JAMA 242 (17): sid. 1900–1901. doi:10.1001/jama.1979.03300170046029. PMID 573343.